
Latest Headlines


May 23, 2025
Early-Phase Trial Shows Activity and Safety of Zongertinib in Previously Treated HER2-Mutant NSCLC
The ASCO Post


May 23, 2025
FDA Approves Doublet for KRAS-Mutated, Recurrent, Low-Grade Serous Ovarian Cancer
The ASCO Post

Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

May 23, 2025
Bringing Evidence-Based Integrative Medicine Into Everyday Oncology Practice
The ASCO Post

May 23, 2025
Together, We’re Building a Better Future for People With Cancer and for Our Profession
The ASCO Post


May 23, 2025
The Legal Impacts on Oncology Care of Prohibiting Diversity, Equity, and Inclusion Efforts
The ASCO Post
Advertisement
Recommendations
Advertisement